110 related articles for article (PubMed ID: 2336196)
1. Identification and distribution of 5-HT3 recognition sites within the human brainstem.
Barnes JM; Barnes NM; Costall B; Deakin JF; Ironside JW; Kilpatrick GJ; Naylor RJ; Rudd JA; Simpson MD; Slater P
Neurosci Lett; 1990 Mar; 111(1-2):80-6. PubMed ID: 2336196
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of 5-HT3 binding sites in NG108-15, NCB-20 neuroblastoma cells and rat cerebral cortex using [3H]-quipazine and [3H]-GR65630 binding.
Sharif NA; Wong EH; Loury DN; Stefanich E; Michel AD; Eglen RM; Whiting RL
Br J Pharmacol; 1991 Apr; 102(4):919-25. PubMed ID: 1830236
[TBL] [Abstract][Full Text] [Related]
3. Binding of the 5-HT3 ligand, [3H]GR65630, to rat area postrema, vagus nerve and the brains of several species.
Kilpatrick GJ; Jones BJ; Tyers MB
Eur J Pharmacol; 1989 Jan; 159(2):157-64. PubMed ID: 2707305
[TBL] [Abstract][Full Text] [Related]
4. Autoradiographic distribution of [3H]-(S)-zacopride-labelled 5-HT3 receptors in human brain.
Parker RM; Barnes JM; Ge J; Barber PC; Barnes NM
J Neurol Sci; 1996 Dec; 144(1-2):119-27. PubMed ID: 8994113
[TBL] [Abstract][Full Text] [Related]
5. Topographical distribution of 5-HT3 receptor recognition sites in the ferret brain stem.
Barnes JM; Barnes NM; Costall B; Naylor IL; Naylor RJ; Rudd JA
Naunyn Schmiedebergs Arch Pharmacol; 1990 Jul; 342(1):17-21. PubMed ID: 2402300
[TBL] [Abstract][Full Text] [Related]
6. Identification and distribution of 5-HT3 recognition sites in the rat gastrointestinal tract.
Champaneria S; Costall B; Naylor RJ; Robertson DW
Br J Pharmacol; 1992 Jul; 106(3):693-6. PubMed ID: 1504752
[TBL] [Abstract][Full Text] [Related]
7. Labelling of 5-HT3 receptor recognition sites in the rat brain using the agonist radioligand [3H]meta-chlorophenylbiguanide.
Steward LJ; West KE; Kilpatrick GJ; Barnes NM
Eur J Pharmacol; 1993 Oct; 243(1):13-8. PubMed ID: 8253120
[TBL] [Abstract][Full Text] [Related]
8. The distribution of specific binding of the 5-HT3 receptor ligand [3H]GR65630 in rat brain using quantitative autoradiography.
Kilpatrick GJ; Jones BJ; Tyers MB
Neurosci Lett; 1988 Nov; 94(1-2):156-60. PubMed ID: 3241663
[TBL] [Abstract][Full Text] [Related]
9. Distribution of S(-)-zacopride-insensitive [125I]R(+)-zacopride binding sites in the rat brain and peripheral tissues.
Ge J; Barnes JM; Towers P; Barnes NM
Eur J Pharmacol; 1997 Aug; 332(3):307-12. PubMed ID: 9300265
[TBL] [Abstract][Full Text] [Related]
10. [3H]zacopride: ligand for the identification of 5-HT3 recognition sites.
Barnes NM; Costall B; Naylor RJ
J Pharm Pharmacol; 1988 Aug; 40(8):548-51. PubMed ID: 2907008
[TBL] [Abstract][Full Text] [Related]
11. The distribution of 5-HT3 recognition sites in the marmoset brain.
Jones DN; Barnes NM; Costall B; Domeney AM; Kilpatrick GJ; Naylor RJ; Tyers MB
Eur J Pharmacol; 1992 Apr; 215(1):63-7. PubMed ID: 1516650
[TBL] [Abstract][Full Text] [Related]
12. Distribution of [3H]GR65630 binding in human brain postmortem.
Marazziti D; Betti L; Giannaccini G; Rossi A; Masala I; Baroni S; Cassano GB; Lucacchini A
Neurochem Res; 2001 Mar; 26(3):187-90. PubMed ID: 11495540
[TBL] [Abstract][Full Text] [Related]
13. Quantitative autoradiographic mapping of 5-HT3 receptors in the rat CNS using [125I]iodo-zacopride and [3H]zacopride as radioligands.
Laporte AM; Koscielniak T; Ponchant M; Vergé D; Hamon M; Gozlan H
Synapse; 1992 Apr; 10(4):271-81. PubMed ID: 1585260
[TBL] [Abstract][Full Text] [Related]
14. Identification of serotonin 5-HT3 recognition sites in membranes of N1E-115 neuroblastoma cells by radioligand binding.
Hoyer D; Neijt HC
Mol Pharmacol; 1988 Mar; 33(3):303-9. PubMed ID: 3352595
[TBL] [Abstract][Full Text] [Related]
15. Characterisation and autoradiographic localisation of 5-HT3 receptor recognition sites identified with [3H]-(S)-zacopride in the forebrain of the rat.
Barnes JM; Barnes NM; Champaneria S; Costall B; Naylor RJ
Neuropharmacology; 1990 Nov; 29(11):1037-45. PubMed ID: 2087255
[TBL] [Abstract][Full Text] [Related]
16. The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro.
Wong EH; Clark R; Leung E; Loury D; Bonhaus DW; Jakeman L; Parnes H; Whiting RL; Eglen RM
Br J Pharmacol; 1995 Feb; 114(4):851-9. PubMed ID: 7773546
[TBL] [Abstract][Full Text] [Related]
17. Characterization of (S)-des-4-amino-3-[125I]iodozacopride ([125I]DAIZAC), a selective high-affinity radioligand for 5-hydroxytryptamine3 receptors.
Hewlett WA; Trivedi BL; Zhang ZJ; de Paulis T; Schmidt DE; Lovinger DM; Ansari MS; Ebert MH
J Pharmacol Exp Ther; 1999 Jan; 288(1):221-31. PubMed ID: 9862774
[TBL] [Abstract][Full Text] [Related]
18. Localization of 5-HT3 receptors in the rat brain using [3H]LY278584.
Gehlert DR; Gackenheimer SL; Wong DT; Robertson DW
Brain Res; 1991 Jul; 553(1):149-54. PubMed ID: 1933271
[TBL] [Abstract][Full Text] [Related]
19. 5-HT transporter sites and 5-HT1A and 5-HT3 receptors in Fawn-Hooded rats: a quantitative autoradiography study.
Chen F; Lawrence AJ
Alcohol Clin Exp Res; 2000 Jul; 24(7):1093-102. PubMed ID: 10924015
[TBL] [Abstract][Full Text] [Related]
20. Radioligand binding and photoaffinity labelling studies show a direct interaction of phenothiazines at 5-HT3 receptors.
Lummis SC; Baker J
Neuropharmacology; 1997; 36(4-5):665-70. PubMed ID: 9225292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
